Henry McCusker's  Instablog

Henry McCusker
Send Message
Analyst, Journalist and Publisher ... Henry enters his tenth (10) year at Scimitar Equity -Regenerative Medicine Investors which aggregates, curates and creates bottom-line content weeding of regenerative medicine and cell therapy news to provide a customized, vetted selection of relevant and... More
My company:
Scimitar Equity-Regenerative Medicine Investors
My blog:
Scimitar Equity Blog
  • 1 for 8 Reverse Stock Split, Aastrom Biosciences (NASDAQ: ASTM) 2 comments
    Feb 9, 2010 9:47 AM

    Aastrom has approved a 1 for 8 reverse stock split of the common stock effective on 2/18/10. The reverse stock split should help ASTM’ shares reflect the value created through their clinical programs and might help attract more institutional ownership of the stock.  The reverse stock split is intended to increase the per share trading price of ASTM’s common stock to satisfy the $1.00 minimum bid price requirement for continued listing on NASDAQ.  Following the reverse stock split, ASTM expects to have approximately 28.3 M shares of common stock outstanding.

    ASTM is currently conducting late-stage clinical trials of their cardiac and vascular repair cell technology and should report the results of the  limb ischemia clinical trial later this month and the dilated cardiomyopathy study later this year.

    • As a result of the recent $13.5 M stock offering and much stronger balance sheet,  ASTM now has the resources to complete patient enrollment in these trials, initiate new clinical studies in these indications in 2010 and execute these programs.

    ASTM filed an amendment to its articles of incorporation to affect the reverse stock split, which was authorized by shareholders at Aastrom’s annual meeting in 12/09.

    • As a result of the reverse stock split, every 8 shares of ASTM’s  common stock that were issued and outstanding immediately prior to the opening of trading on 2/18/10 will automatically be combined into 1 issued and outstanding share without any change in the par value of such shares and the number of authorized but un-issued shares of ASTM’s common stock will be proportionally reduced.
    • .No fractional shares of common stock will be issued as a result of the reverse stock split and shareholders of record will receive cash in lieu of fractional shares to which they would otherwise be entitled, based upon the closing price of Aastrom’s common stock on 2/17/10.
Back To Henry McCusker's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (2)
Track new comments
  • pslice84
    , contributor
    Comments (323) | Send Message
    is this a good thing? would it get shorted to hell after the split?
    9 Feb 2010, 07:37 PM Reply Like
  • GelsiCapital
    , contributor
    Comments (12) | Send Message
    Man do I hate reverse stock splits look at etrade for an example
    17 Jul 2010, 01:40 PM Reply Like
Full index of posts »
Latest Followers


  • ImmunoCellular (OTC BB: IMUC) files to Sell $13.8M of Units via Cowen
    Nov 30, 2011
  • Mid-Day Movers: BioTime (AMEX: BTX), Cytori (CYTX), Geron (GERN), Neuralstem (AMEX: CUR), ReNeuron (RENE.LON), ThermoGenesis (KOOL)
    Oct 26, 2011
More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.